Brenntag names Anthony Gerace to lead global Mergers & Acquisitions for Brenntag Group

Brenntag announces that Anthony Gerace will be promoted to Managing Director Mergers & Acquisitions for the Group, effective March 1, 2014.

In this new position Anthony Gerace will lead the Group's Mergers & Acquisitions team to focus on further expansion, in line with Brenntag's strategy. Anthony Gerace will report to Steven Holland, Chief Executive Officer.

Anthony Gerace joined Brenntag in 1993 and is currently responsible for Mergers & Acquisitions activities in the Brenntag North American organization. During his tenure with the company he has accumulated significant expertise in successfully managing operating companies in addition to directing strategic Mergers & Acquisitions projects for Brenntag in North America.

Brenntag Group's Chief Executive Officer Steven Holland: "I'm delighted to announce the appointment of Anthony Gerace as Managing Director Mergers & Acquisitions. He is singularly qualified for this role. As a knowledgeable professional in this field, he brings especially strong expertise in the Mergers & Acquisitions sphere and will support Brenntag's already successful track record in this important area." 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.